Loading stock data…
Loading stock data…
US$25.60
Get one email when PCRX crosses your level. Checked every 15 minutes during market hours.
▲ +0.27 (1.07%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
62.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.55
Bullish momentumMACD above its signal line (0.54).
50-day average
23.79
Price aboveShort-term trend reference.
200-day average
23.37
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - Specialty & Generic
Pacira BioSciences Inc. is a biopharmaceutical company dedicated to developing, manufacturing, and commercializing innovative non-opioid pain management therapies. Its primary focus is transforming patient care by providing opioid-sparing alternatives for acute, postsurgical, chronic, and musculoskeletal pain, including commercial products like EXPAREL (bupivacaine liposome injectable suspension) for long-acting local analgesia and iovera, which delivers precise cryoneurolysis to targeted nerves…
www.pacira.com3 strong buy · 5 buy · 3 hold · 1 sell · 0 strong sell (12 analysts, 2026-07-01)
3 strong buy · 6 buy · 3 hold · 1 sell · 0 strong sell (13 analysts, 2026-06-01)
3 strong buy · 6 buy · 3 hold · 1 sell · 0 strong sell (13 analysts, 2026-05-01)
3 strong buy · 6 buy · 3 hold · 1 sell · 0 strong sell (13 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-04-30 | 0.56 | 0.6 | ✓ Beat |
| 2026-02-26 | 0.9 | 0.57 | ✗ Miss |
| 2026-02-12 | 1.03 | 1.07 | ✓ Beat |
| 2026-01-15 | 2.98 | 3.14 | ✓ Beat |
| 2025-11-06 | 0.65 | 0.7 | ✓ Beat |
| 2025-08-05 | 0.71 | 0.74 | ✓ Beat |
| 2025-05-08 | 0.6 | 0.62 | ✓ Beat |
| 2025-02-27 | 0.83 | 0.91 | ✓ Beat |
Companies in the same industry, via Finnhub